Literature DB >> 15607800

PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.

Daniela Pende1, Cristina Bottino, Roberta Castriconi, Claudia Cantoni, Stefania Marcenaro, Paola Rivera, Grazia M Spaggiari, Alessandra Dondero, Barbara Carnemolla, Nicolas Reymond, Maria Cristina Mingari, Marc Lopez, Lorenzo Moretta, Alessandro Moretta.   

Abstract

The capability of NK lymphocytes to kill tumor cells depends on different receptors/ligands interactions. In order to identify the cellular ligands recognized by "orphan" triggering receptors, mice were immunized with NK susceptible target cells. mAbs were selected that inhibited NK cytotoxicity and recognized two different molecules of 70 and 60-65 kDa. Tryptic digestion and mass spectra analysis of purified proteins identified these molecules as PVR and Nectin-2, respectively. PVR-Fc and Nectin-2-Fc chimeric molecules stained COS-7 cells expressing the DNAM-1 activating receptor and conversely, PVR and Nectin-2 CHO-K cell transfectants were stained by DNAM-1-Fc. Thus, both PVR and Nectin-2 represent specific ligands for DNAM-1. Importantly, the specific interaction between DNAM-1 (in NK cells) and PVR or Nectin-2 (in target cells) enhanced the NK-mediated lysis of tumor cells that was downregulated by mAb-mediated masking of the receptor or its ligands.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15607800     DOI: 10.1016/j.molimm.2004.07.028

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  46 in total

Review 1.  From markers to molecular mechanisms: type 1 diabetes in the post-GWAS era.

Authors:  Alan G Baxter; Margaret A Jordan
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 2.  A novel interface consisting of homologous immunoglobulin superfamily members with multiple functions.

Authors:  Zhuwei Xu; Boquan Jin
Journal:  Cell Mol Immunol       Date:  2010-01       Impact factor: 11.530

3.  The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity.

Authors:  Noa Stanietsky; Hrvoje Simic; Jurica Arapovic; Amir Toporik; Ofer Levy; Amit Novik; Zurit Levine; Meirav Beiman; Liat Dassa; Hagit Achdout; Noam Stern-Ginossar; Pinhas Tsukerman; Stipan Jonjic; Ofer Mandelboim
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

4.  Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors.

Authors:  Andrea Acebes-Huerta; Seila Lorenzo-Herrero; Alicia R Folgueras; Leticia Huergo-Zapico; Carlos Lopez-Larrea; Alejandro López-Soto; Segundo Gonzalez
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

5.  Vstm3 is a member of the CD28 family and an important modulator of T-cell function.

Authors:  Steven D Levin; David W Taft; Cameron S Brandt; Christoph Bucher; Edward D Howard; Eric M Chadwick; Janet Johnston; Angela Hammond; Kristen Bontadelli; Daniel Ardourel; LuAnn Hebb; Anitra Wolf; Thomas R Bukowski; Mark W Rixon; Joseph L Kuijper; Craig D Ostrander; James W West; Janine Bilsborough; Brian Fox; Zeren Gao; Wenfeng Xu; Fred Ramsdell; Bruce R Blazar; Katherine E Lewis
Journal:  Eur J Immunol       Date:  2011-03-18       Impact factor: 5.532

Review 6.  Nectin family of cell-adhesion molecules: structural and molecular aspects of function and specificity.

Authors:  Dibyendu Samanta; Steven C Almo
Journal:  Cell Mol Life Sci       Date:  2014-10-19       Impact factor: 9.261

Review 7.  Molecular mechanisms of natural killer cell activation in response to cellular stress.

Authors:  C J Chan; M J Smyth; L Martinet
Journal:  Cell Death Differ       Date:  2013-04-12       Impact factor: 15.828

8.  CD226 protein is involved in immune synapse formation and triggers Natural Killer (NK) cell activation via its first extracellular domain.

Authors:  Shengke Hou; Kuikui Ge; Xiaodong Zheng; Haiming Wei; Rui Sun; Zhigang Tian
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

Review 9.  Mast cells and eosinophils: the two key effector cells in allergic inflammation.

Authors:  Yael Minai-Fleminger; Francesca Levi-Schaffer
Journal:  Inflamm Res       Date:  2009-05-08       Impact factor: 4.575

10.  Increased levels of soluble CD226 in sera accompanied by decreased membrane CD226 expression on peripheral blood mononuclear cells from cancer patients.

Authors:  Zhuwei Xu; Tao Zhang; Ran Zhuang; Yun Zhang; Wei Jia; Chaojun Song; Kun Yang; Angang Yang; Boquan Jin
Journal:  BMC Immunol       Date:  2009-06-02       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.